These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24887014)

  • 1. Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication.
    Denies S; Cicchelero L; Van Audenhove I; Sanders NN
    J Control Release; 2014 Aug; 187():175-82. PubMed ID: 24887014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
    Hermans IF; Chong TW; Palmowski MJ; Harris AL; Cerundolo V
    Cancer Res; 2003 Dec; 63(23):8408-13. PubMed ID: 14679003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer: A pilot study.
    Cicchelero L; Denies S; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
    Cancer Lett; 2017 Aug; 400():205-218. PubMed ID: 27693635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model.
    Son CH; Shin DY; Kim SD; Park HS; Jung MH; Bae JH; Kang CD; Yang K; Park YS
    J Immunother; 2012 Oct; 35(8):607-14. PubMed ID: 22996366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and synergistic control of Ph(+) ALL by a DNA vaccine and 6-mercaptopurine.
    Köchling J; Rott Y; Arndt S; Marschke C; Schmidt M; Wittig B; Kalies K; Westermann J; Henze G
    Vaccine; 2012 Sep; 30(41):5949-55. PubMed ID: 22841975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of flk1-based DNA vaccine and an immunomodulatory gene (IL-12) in the treatment of murine cancer.
    Keke F; Hongyang Z; Hui Q; Jixiao L; Jian C
    Cancer Biother Radiopharm; 2004 Oct; 19(5):649-57. PubMed ID: 15650458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.
    Jarosz M; Jazowiecka-Rakus J; Cichoń T; Głowala-Kosińska M; Smolarczyk R; Smagur A; Malina S; Sochanik A; Szala S
    Gene Ther; 2013 Mar; 20(3):262-73. PubMed ID: 22495576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.
    Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S
    Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.
    Miguel A; Herrero MJ; Sendra L; Botella R; Algás R; Sánchez M; Aliño SF
    Cancer Gene Ther; 2013 Oct; 20(10):576-81. PubMed ID: 23969885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
    Hoffmann D; Bayer W; Wildner O
    Int J Mol Med; 2007 Nov; 20(5):673-81. PubMed ID: 17912460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
    Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine.
    Igoucheva O; Grazzini M; Pidich A; Kemp DM; Larijani M; Farber M; Lorton J; Rodeck U; Alexeev V
    Gene Ther; 2013 Sep; 20(9):939-48. PubMed ID: 23552473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
    Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
    Torrero M; Li S
    Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.